Literature DB >> 8798421

Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime.

C Cantu1, W Huang, T Palzkill.   

Abstract

Recently, natural variants of TEM-1 beta-lactamase with amino acid substitutions at residues 237-240 have been identified that have increased hydrolytic activity for extended-spectrum antibiotics such as ceftazidime. To identify the sequence requirements in this region for a given antibiotic, a random library was constructed that contained all possible amino acid combinations for the 3-residue region 237-240 (ABL numbering system) of TEM-1 beta-lactamase. An antibiotic disc diffusion method was used to select mutants with wild-type level activity or greater for the extended-spectrum cephalosporin ceftazidime and the monobactam aztreonam. Mutants that were selected for optimal ceftazidime hydrolysis contained a conserved Ala at position 237, a Ser for Gly substitution at position 238, and a Lys for Glu at position 240. Mutants selected for aztreonam hydrolysis exhibited a Gly for Ala substitution at position 237, a Ser for Gly substitution at position 238, and a Lys/Arg for Glu at position 240. The role of the A237G substitution in differentiating between ceftazidime and aztreonam was further investigated by kinetic analysis of the A237G, E240K, G238S:E240K, and A237G:G238S:E240K enzymes. The A237G single mutant and the G238S:E240K double mutant exhibited increases in catalytic efficiency for both ceftazidime and aztreonam. However, the triple mutant A237G:G238S:E240K, displayed a 12-fold decrease in catalytic efficiency for ceftazidime but a 3-fold increase for aztreonam relative to the G238S:E240K double mutant. Thus, the A237G substitution increases ceftazidime hydrolysis when present alone but antagonizes ceftazidime hydrolysis when it is combined with the G238S:E240K substitutions. In contrast, the A237G substitution acts additively with the G238S:E240K substitutions to increase aztreonam hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798421     DOI: 10.1074/jbc.271.37.22538

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Biochemical-genetic analysis and distribution of FAR-1, a class A beta-lactamase from Nocardia farcinica.

Authors:  F Laurent; L Poirel; T Naas; E B Chaibi; R Labia; P Boiron; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

2.  Characterization of TEM-56, a novel beta-lactamase produced by a Klebsiella pneumoniae clinical isolate.

Authors:  C Neuwirth; R Labia; E Siebor; A Pechinot; S Madec; E B Chaibi; A Kazmierczak
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Identification of residues critical for metallo-beta-lactamase function by codon randomization and selection.

Authors:  I C Materon; T Palzkill
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

4.  Binding properties of a peptide derived from beta-lactamase inhibitory protein.

Authors:  G W Rudgers; W Huang; T Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

5.  TEM-71, a novel plasmid-encoded, extended-spectrum beta-lactamase produced by a clinical isolate of Klebsiella pneumoniae.

Authors:  J Kamile Rasheed; Gregory J Anderson; Anne Marie Queenan; James W Biddle; Antonio Oliver; George A Jacoby; Karen Bush; Fred C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 6.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

7.  bla(SHV) Genes in Klebsiella pneumoniae: different allele distributions are associated with different promoters within individual isolates.

Authors:  David S Hammond; Jacqueline M Schooneveldt; Graeme R Nimmo; Flavia Huygens; Philip M Giffard
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

8.  Active TEM-1 beta-lactamase mutants with random peptides inserted in three contiguous surface loops.

Authors:  Pascale Mathonet; Julie Deherve; Patrice Soumillion; Jacques Fastrez
Journal:  Protein Sci       Date:  2006-09-08       Impact factor: 6.725

9.  High tolerance to simultaneous active-site mutations in TEM-1 beta-lactamase: Distinct mutational paths provide more generalized beta-lactam recognition.

Authors:  Pierre-Yves De Wals; Nicolas Doucet; Joelle N Pelletier
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

10.  Novel ceftazidime-resistance beta-lactamases generated by a codon-based mutagenesis method and selection.

Authors:  Paul Gaytán; Joel Osuna; Xavier Soberón
Journal:  Nucleic Acids Res       Date:  2002-08-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.